Celularity CELU
NASDAQ CELU
$1.38 +0.03 (+2.22%)
At close: Oct 1, 2026 · 4:00 PM EDT

Celularity (CELU) Goodwill impairment charges (2022 - 2023)

Updated

Celularity (CELU) reported Goodwill impairment charges of $112.35 million for FY2023, compared with $3.61 million in FY2022.

Analysis

Celularity (CELU) Goodwill impairment charges (2022 - 2023) Analysis & Trends

  • According to Business Quant data, Goodwill impairment charges came in at $3.61 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Celularity 39.39 Mn 31.87 Mn 2.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 82.71 Mn
Mar 31, 2023 29.63 Mn
Dec 31, 2022 3.61 Mn
API Access

Celularity Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=CELU&period=max&api_key=YOUR_API_KEY